163 related articles for article (PubMed ID: 30266801)
1. Targeting Lineage-specific MITF Pathway in Human Melanoma Cell Lines by A-485, the Selective Small-molecule Inhibitor of p300/CBP.
Wang R; He Y; Robinson V; Yang Z; Hessler P; Lasko LM; Lu X; Bhathena A; Lai A; Uziel T; Lam LT
Mol Cancer Ther; 2018 Dec; 17(12):2543-2550. PubMed ID: 30266801
[TBL] [Abstract][Full Text] [Related]
2. The C-terminal transactivation domain of MITF interacts promiscuously with co-activator CBP/p300.
Brown AD; Lynch K; Langelaan DN
Sci Rep; 2023 Sep; 13(1):16094. PubMed ID: 37752231
[TBL] [Abstract][Full Text] [Related]
3. Acetylation reprograms MITF target selectivity and residence time.
Louphrasitthiphol P; Loffreda A; Pogenberg V; Picaud S; Schepsky A; Friedrichsen H; Zeng Z; Lashgari A; Thomas B; Patton EE; Wilmanns M; Filippakopoulos P; Lambert JP; Steingrímsson E; Mazza D; Goding CR
Nat Commun; 2023 Sep; 14(1):6051. PubMed ID: 37770430
[TBL] [Abstract][Full Text] [Related]
4. A pro-apoptotic function of iASPP by stabilizing p300 and CBP through inhibition of BRMS1 E3 ubiquitin ligase activity.
Kramer D; Schön M; Bayerlová M; Bleckmann A; Schön MP; Zörnig M; Dobbelstein M
Cell Death Dis; 2015 Feb; 6(2):e1634. PubMed ID: 25675294
[TBL] [Abstract][Full Text] [Related]
5. Inducibly decreased MITF levels do not affect proliferation and phenotype switching but reduce differentiation of melanoma cells.
Vlčková K; Vachtenheim J; Réda J; Horák P; Ondrušová L
J Cell Mol Med; 2018 Apr; 22(4):2240-2251. PubMed ID: 29369499
[TBL] [Abstract][Full Text] [Related]
6. Bromodomain inhibition of the coactivators CBP/EP300 facilitate cellular reprogramming.
Ebrahimi A; Sevinç K; Gürhan Sevinç G; Cribbs AP; Philpott M; Uyulur F; Morova T; Dunford JE; Göklemez S; Arı Ş; Oppermann U; Önder TT
Nat Chem Biol; 2019 May; 15(5):519-528. PubMed ID: 30962627
[TBL] [Abstract][Full Text] [Related]
7. Genome-wide assessment of differential roles for p300 and CBP in transcription regulation.
Ramos YF; Hestand MS; Verlaan M; Krabbendam E; Ariyurek Y; van Galen M; van Dam H; van Ommen GJ; den Dunnen JT; Zantema A; 't Hoen PA
Nucleic Acids Res; 2010 Sep; 38(16):5396-408. PubMed ID: 20435671
[TBL] [Abstract][Full Text] [Related]
8. A Dual-Site Inhibitor of CBP/p300 KIX is a Selective and Effective Modulator of Myb.
Joy ST; Henley MJ; De Salle SN; Beyersdorf MS; Vock IW; Huldin AJL; Mapp AK
J Am Chem Soc; 2021 Sep; 143(37):15056-15062. PubMed ID: 34491719
[TBL] [Abstract][Full Text] [Related]
9. High MITF Expression Is Associated with Super-Enhancers and Suppressed by CDK7 Inhibition in Melanoma.
Eliades P; Abraham BJ; Ji Z; Miller DM; Christensen CL; Kwiatkowski N; Kumar R; Njauw CN; Taylor M; Miao B; Zhang T; Wong KK; Gray NS; Young RA; Tsao H
J Invest Dermatol; 2018 Jul; 138(7):1582-1590. PubMed ID: 29408204
[TBL] [Abstract][Full Text] [Related]
10. pH-controlled histone acetylation amplifies melanocyte differentiation downstream of MITF.
Raja DA; Gotherwal V; Burse SA; Subramaniam YJ; Sultan F; Vats A; Gautam H; Sharma B; Sharma S; Singh A; Sivasubbu S; Gokhale RS; Natarajan VT
EMBO Rep; 2020 Jan; 21(1):e48333. PubMed ID: 31709752
[TBL] [Abstract][Full Text] [Related]
11. Gene expression profiling identifies microphthalmia-associated transcription factor (MITF) and Dickkopf-1 (DKK1) as regulators of microenvironment-driven alterations in melanoma phenotype.
Hartman ML; Talar B; Noman MZ; Gajos-Michniewicz A; Chouaib S; Czyz M
PLoS One; 2014; 9(4):e95157. PubMed ID: 24733089
[TBL] [Abstract][Full Text] [Related]
12. Loss of p300 and CBP disrupts histone acetylation at the mouse Sry promoter and causes XY gonadal sex reversal.
Carré GA; Siggers P; Xipolita M; Brindle P; Lutz B; Wells S; Greenfield A
Hum Mol Genet; 2018 Jan; 27(1):190-198. PubMed ID: 29145650
[TBL] [Abstract][Full Text] [Related]
13. Discovery of Highly Potent and Efficient CBP/p300 Degraders with Strong
Hu J; Xu H; Wu T; Zhang C; Shen H; Dong R; Hu Q; Xiang Q; Chai S; Luo G; Chen X; Huang Y; Zhao X; Peng C; Wu X; Lin B; Zhang Y; Xu Y
J Med Chem; 2024 May; 67(9):6952-6986. PubMed ID: 38649304
[TBL] [Abstract][Full Text] [Related]
14. Microphthalmia-associated transcription factor in melanoma development and MAP-kinase pathway targeted therapy.
Wellbrock C; Arozarena I
Pigment Cell Melanoma Res; 2015 Jul; 28(4):390-406. PubMed ID: 25818589
[TBL] [Abstract][Full Text] [Related]
15. Transcriptional and post-translational regulation of MITF mediated by bHLH domain during the melanogenesis and melanocyte proliferation in Crassostrea gigas.
Min Y; Yu H; Li Q
Int J Biol Macromol; 2024 May; 266(Pt 2):131138. PubMed ID: 38547943
[TBL] [Abstract][Full Text] [Related]
16. MITF controls the TCA cycle to modulate the melanoma hypoxia response.
Louphrasitthiphol P; Ledaki I; Chauhan J; Falletta P; Siddaway R; Buffa FM; Mole DR; Soga T; Goding CR
Pigment Cell Melanoma Res; 2019 Nov; 32(6):792-808. PubMed ID: 31207090
[TBL] [Abstract][Full Text] [Related]
17. A common intronic variant of PARP1 confers melanoma risk and mediates melanocyte growth via regulation of MITF.
Choi J; Xu M; Makowski MM; Zhang T; Law MH; Kovacs MA; Granzhan A; Kim WJ; Parikh H; Gartside M; Trent JM; Teulade-Fichou MP; Iles MM; Newton-Bishop JA; Bishop DT; MacGregor S; Hayward NK; Vermeulen M; Brown KM
Nat Genet; 2017 Sep; 49(9):1326-1335. PubMed ID: 28759004
[TBL] [Abstract][Full Text] [Related]
18. Discovery of novel CBP bromodomain inhibitors through TR-FRET-based high-throughput screening.
Zhang FC; Sun ZY; Liao LP; Zuo Y; Zhang D; Wang J; Chen YT; Xiao SH; Jiang H; Lu T; Xu P; Yue LY; Du DH; Zhang H; Liu CP; Luo C
Acta Pharmacol Sin; 2020 Feb; 41(2):286-292. PubMed ID: 31253937
[TBL] [Abstract][Full Text] [Related]
19. A role for ATF2 in regulating MITF and melanoma development.
Shah M; Bhoumik A; Goel V; Dewing A; Breitwieser W; Kluger H; Krajewski S; Krajewska M; Dehart J; Lau E; Kallenberg DM; Jeong H; Eroshkin A; Bennett DC; Chin L; Bosenberg M; Jones N; Ronai ZA
PLoS Genet; 2010 Dec; 6(12):e1001258. PubMed ID: 21203491
[TBL] [Abstract][Full Text] [Related]
20. A CRISPR Interference of CBP and p300 Selectively Induced Synthetic Lethality in Bladder Cancer Cells
Li J; Huang C; Xiong T; Zhuang C; Zhuang C; Li Y; Ye J; Gui Y
Int J Biol Sci; 2019; 15(6):1276-1286. PubMed ID: 31223286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
